transparent gif
ImmuneSupport.com Home  
New Trial of Constipation Predominant IBS Treatment Now Recruiting at 69 Centers in U.S. & Canada
Fibromyalgia & Chronic Fatigue Syndrome Home Page Fibromyalgia & Chronic Fatigue Syndrome Library Fibromyalgia & Chronic Fatigue Syndrome Treatment and Research Email bulletins Fibromyalgia & Chronic Fatigue Syndrome Products Fibromyalgia & Chronic Fatigue Syndrome Community Area Fibromyalgia & Chronic Fatigue Syndrome About Us transparent gif transparent gif
transparent gif
Health Watch Newsletter background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
Home
Fibromyalgia Resources

Chronic Fatigue Syndrome Resources

E-mail Bulletin
Store
Community
About Us

Your Support Funds Research & Advocacy

New Trial of Constipation Predominant IBS Treatment Now Recruiting at 69 Centers in U.S. & Canada


ImmuneSupport.com

11-24-2007

Advertisement
This Phase 2b trial involving a drug to be taken orally for symptom relief of constipation predominant IBS (ClinicalTrials.gov number NCT00547469) is enrolling female patients only – at 69 sites in more than 20 U.S. states and across Canada.

The drug - pumosetrag (DDP733) – is said to mimic the effect of the neurotransmitter serotonin, which is known to be involved in control of the gastrointestinal system.

For details of this large-scale pharmaceutical firm-sponsored study, visit the study listing at ClinicalTrials.gov.

For those who may be interested in participating, the ClinicalTrials.gov description includes a link to a separate site with more information about the trial and the trial sites (http://www.pictureibs.com) – plus an interactive eligibility-screening questionnaire.

  Newsletter SignUp Discuss (1 comments) Email Article Print Page
Related Articles:
Antidepressant found to alleviate symptoms of Irritable Bowel Syndrome in adolescents
Rating of 3
Treatment blocks pain without disrupting other functions
Rating of 3.1
FDA Approves First Drug for Treating Fibromyalgia
Rating of 3
Will Duloxetine Be First FDA-Approved Fibromyalgia Therapy?
Rating of 3.1
Pain as a Constant, Invisible Companion
Rating of 3.1

Every purchase funds research, donations and the community resources provided within our website.

Guaifenesin
Extended Release, Fast Acting, Ultra Pure. Used in Dr. St Amand Protocol.
ImmuneSupport.com


New Energy NADH
Increase mental sharpness, energy, concentration. Stimulant free NADH.
ImmuneSupport.com


B-12 Extreme
Most potent single dose of B-12. Increase energy & mental clarity.
ImmuneSupport.com


Green Tea Mega EGCG Boost your immune system & protect cells from damage. 290mg EGCG.
ImmuneSupport.com


Neptune Krill Oil
For optimal omega-3 absorption. 100% pure.
ImmuneSupport.com


Fuel Your Energy
CorvalenM with D-Ribose, magnesium & malic acid.
ImmuneSupport.com


At ProHealth we believe in "commerce with compassion."

Weekly Special



DISCUSS THIS ARTICLE  (1 existing comments)
343rd most popular article of 388 discussed articles
Sort by: Date | Score | Username
Post a Comment

Drug Trials
Posted by: diegolady
Dec 6, 2007
Why is 65 the magical cut off age for people doing drug trials? Except for Fibro and some arthritis, I am in good health for my age (74). Goodness knows, aren't we the ones needing most of this stuff?
Reply Reply



Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's ImmuneSupport.com- The World's Largest Fibromyalgia & Chronic Fatigue Syndrome Website!
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee